References
- Ross G. Gestational diabetes. Aust Fam Physician. 2006;35(6):392–396.
- Donovan PJ, McIntyre HD. Drugs for gestational diabetes. Aust Prescr. 2010;33(5):141–144.
- Chu SY, Callaghan WM, Kim SY, et al. Maternal obesity and risk of gestational diabetes mellitus. Diabetes Care. 2007;30(8):2070–2076.
- Carpenter MW. Gestational diabetes, pregnancy hypertension, and late vascular disease. Diabetes Care. 2007;30(Supplement 2):S246–S250.
- Clausen TD, Mathiesen ER, Torben H, et al. Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes. J Clin Endocrinol Metab. 2009;94(7):2464–2470.
- Vania J, Gernot D, Boris N, et al. Epigenetic regulation of human placental function and pregnancy outcome: considerations for causal inference. Am J Obstet Gynecol. 2015;213(4):S182–S196.
- Radaelli T, Varastehpour A, Catalano P, et al. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes. 2003;52(12):2951–2958.
- Tatiana R, Jacques L, Ali V, et al. Differential regulation of genes for fetoplacental lipid pathways in pregnancy with gestational and type 1 diabetes mellitus. Am J Obstet Gynecol. 2009;201(2):209.e1–209.e10.
- Enquobahrie DA, Williams MA, Chunfang Q, et al. Global placental gene expression in gestational diabetes mellitus. Am J Obstet Gynecol. 2009;200(2):206.e1–206.e13.
- Haubner F, Lehle K, Münzel D, et al. Hyperglycemia increases the levels of vascular cellular adhesion molecule-1 and monocyte-chemoattractant-protein-1 in the diabetic endothelial cell. Biochem Biophys Res Commun. 2007;360(3):560–565.
- Cvitic S, Novakovic B, Gordon L, et al. Human fetoplacental arterial and venous endothelial cells are differentially programmed by gestational diabetes mellitus, resulting in cell-specific barrier function changes. Diabetologia. 2018;61(11):2398–2411.
- Carvalho BS, Irizarry RA. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 2010;26(19):2363–2367.
- Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey VJ, Huber W, editors. Bioinformatics and computational biology solutions using R and bioconductor. New York, NY: Springer New York; 2005. p. 397–420.
- Kanehisa M, Goto S. KEGG: Kyoto Encyclopedia of Genes and Genomes. Nucleic Acids Res. 2000;28(1):27–30.
- Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology [Commentary]. Nat Genet. 2000;25(1):25–29.
- Yu G, Wang L, Han Y, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284–287.
- Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein–protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2014;43:D447–D452.
- Shannon P, Markiel A, Ozier O, et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 2003;13(11):2498–2504.
- Davis AP, Grondin CJ, Johnson RJ, et al. The Comparative Toxicogenomics Database: update 2019. Nucleic Acids Res. 2019;47:D948–D954.
- Janky R, Verfaillie A, Imrichová H, et al. iRegulon: from a gene list to a gene regulatory network using large motif and track collections. PLoS Comput Biol. 2014;10(7):e1003731.
- Jungheim ES, Moley KH. The impact of type 1 and type 2 diabetes mellitus on the oocyte and the preimplantation embryo. Semin Reprod Med. 2008;26(2):186–195.
- Anja S, Nebreda AR. Signalling pathways in oocyte meiotic maturation. J Cell Sci. 2002;115(12):2457–2459.
- Chang AS, Dale AN, Moley KH. Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis. Endocrinology. 2005;146(5):2445–2453.
- Maiese K. FoxO transcription factors and regenerative pathways in diabetes mellitus. CNR. 2015;12(4):404–413.
- Xu Y, Jin B, Sun L, et al. The expression of FoxO1 in placenta and omental adipose tissue of gestational diabetes mellitus. Exp Clin Endocrinol Diabetes. 2014;122(5):287–294.
- Golson ML, Misfeldt AA, Kopsombut UG, et al. High fat diet regulation of β-cell proliferation and β-cell mass. Open Endocrinol J. 2010;4(4). doi:10.2174/1874216501004010066.
- L LH, H XH. Macro-management of microRNAs in cell cycle progression of tumor cells and its implications in anti-cancer therapy. Acta Pharmacol Sin. 2011;32(11):1311–1320.
- Han W, Wang L, Zhang L, et al. Circular RNA circ-RAD23B promotes cell growth and invasion by miR-593-3p/CCND2 and miR-653-5p/TIAM1 pathways in non-small cell lung cancer. Biochem Biophys Res Commun. 2019;510(3):462–466.
- Rhodes J, Amsterdam A, Ho K, et al. A role for fbxo5 in zebrafish myelopoiesis. Blood. 2005;106(11):3608–3608.
- Stephen S, Maen A. Sp transcription factor family and its role in cancer. Eur J Cancer. 2005;41(16):2438–2448.